Metabolic dysfunction-associated fatty liver disease can significantly increase the risk of chronic kidney disease in adults with type 2 diabetes
Authors:
Open Access
- 2 February 2023
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 197, 110563
Abstract
No abstract availableKeywords
Funding Information
- Guangxi Zhuang Autonomous Region Government
This publication has 36 references indexed in Scilit:
- Worldwide access to treatment for end-stage kidney disease: a systematic reviewThe Lancet, 2015
- Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal DysfunctionPLOS ONE, 2014
- CKD and Nonalcoholic Fatty Liver DiseaseAmerican Journal of Kidney Diseases, 2014
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysisPLOS Medicine, 2014
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroenterologyGastroenterology, 2012
- Prevalence of chronic kidney disease in China: a cross-sectional surveyThe Lancet, 2012
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysisHepatology, 2011
- The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007Diabetologia, 2008
- Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summaryJournal of Gastroenterology and Hepatology, 2007
- Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver DiseaseLaboratory Investigation, 2003